epirubicin has been researched along with Carcinoma, Epidermoid in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (9.52) | 18.7374 |
1990's | 30 (35.71) | 18.2507 |
2000's | 26 (30.95) | 29.6817 |
2010's | 19 (22.62) | 24.3611 |
2020's | 1 (1.19) | 2.80 |
Authors | Studies |
---|---|
Hide, M; Kan, T; Kawai, M; Mizuno, H; Moriwaki, M; Murakami, E; Numata, T; Okamoto, M; Otsuka, R; Sueoka, M; Takahagi, S; Tanaka, A | 1 |
Alan, O; Ercelep, O; Hasanov, R; Kaya, H; Mutis, A; Ones, T; Simsek, ET; Telli, TA; Yumuk, PF | 1 |
Bowrey, DJ; Cunnell, M; Khanna, A; Madhusudan, S; Parsons, SL; Reece-Smith, AM; Thomas, A | 1 |
Corrado, G; Cutillo, G; Maggioni, A; Mancini, E; Tomaselli, T; Vizza, E; Zanagnolo, V | 1 |
Brammer, K; Catton, JA; James, EJ; Parsons, SL; Randhawa, N; Tan, BH; Welch, NT | 1 |
Lee, HP; Lo, YL; Tu, WC | 1 |
Cárdenas-Rebollo, JM; Colombo, N; Maggioni, A; Minig, L; Zanagnolo, V | 1 |
Benson, AB; Burtness, BA; Cohen, SJ; Douglas, K; Enzinger, PC; Goldberg, RM; Ilson, DH; Mayer, RJ; Niedzwiecki, D; Venook, A; Villaflor, VM; Ye, X | 1 |
Chu, SC; Kao, RH; Li, CC; Wang, TF; Yao, CY | 1 |
Bonazzi, C; Chiari, S; Maneo, A; Mangioni, C | 1 |
Nagai, T; Okubo, T; Sakaguchi, R; Seki, H; Takeda, S | 1 |
Chang, JW; Chen, CH; Lin, CM; Tsao, TC | 1 |
Ishiguro, K; Nishimura, M; Suda, T; Uchida, N | 1 |
Chen, LM; Dai, CL; Fu, LW; Liang, YJ; Su, XD; Tao, LY; Wang, FP; Yan, YY; Zhang, X | 1 |
Appadurai, I; Arnold, DT; Blackshaw, G; Crosby, TD; Davies, L; Escofet, X; Evans, M; Gwynne, S; Lewis, WG; Roberts, SA | 1 |
Gossage, JA; Hale, PC; Mamidanna, R; Manifold, DK; Newman, G; Pantling, AZ; Robinson, A | 1 |
Cheong, KA; Chrystal, K; Harper, PG; Karapetis, CS; Marx, G; Steer, C; Strickland, AH; Yip, D; Yip, S | 1 |
Asghar, U; Ashley, S; Ashton, J; Chau, I; Cunningham, D; Hawkes, E; Jackson, K; Okines, AF | 1 |
Barbour, A; Gotley, DC; Hirst, J; Smithers, BM; Thomas, J | 1 |
Cegovnik, U; Kern, I; Korošec, P; Košnik, M; Rijavec, M; Silar, M; Triller, N | 1 |
Chen, Y; Li, H; Liu, DZ; Yan, D; Zeng, HY; Zhou, CW | 1 |
Gilani, SQ; Jain, PK; Pellen, MG; Razack, A; Sabri, S | 1 |
Ashley, S; Chau, I; Cunningham, D; Gujral, DM; Hawkins, MA; Leonulli, BG; Tait, D | 1 |
Matsuo, T; Miyata, Y; Ohba, K; Sagara, Y; Sakai, H; Takahashi, H; Watanabe, S | 1 |
Nakamura, K; Okuyama, R; Saida, T; Uhara, H | 1 |
Ieda, N; Pirovano, C; Siesto, G; Vitobello, D | 1 |
Grem, JL; Leonard, GD; Zhuang, SH | 1 |
Xiao, QM; Zhang, WD; Zhou, JH | 1 |
Hadjileontis, CG; Kaloutsi, VD; Kostopoulos, IS; Kotoula, VA; Nikolaou, AC; Papadimitriou, CS | 1 |
Iwahashi, M; Nakamori, M; Nakamura, M; Yamaue, H | 1 |
Boezen, HM; de Leede, GP; de Vries, EG; Eppinga, P; Erjavec, Z; Groen, HJ; Kramer, H; Strijbos, JH; Van Putten, JW; Wachters, FM | 1 |
Folz, BJ; Külkens, C; Lippert, BM; Teymoortash, A; Werner, JA | 1 |
Liu, BD; Xu, QS; Zhi, XY | 1 |
Atkinson, S; Botha, A; Cheong, K; Chrystal, K; Forshaw, MJ; Gossage, JA; Harper, PG; Mason, RC | 1 |
Cheong, K; Chrystal, K; Forshaw, MJ; Gossage, JA; Harper, PG; Mason, RC | 1 |
Bolgova, LS; Klapchuk, AG; Rodzaevskiĭ, SA; Tuganova, TN | 1 |
Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sung, HJ | 1 |
Bacigalupo, A; Benasso, M; Corvò, R; Gatteschi, B; Marcenaro, M; Ponzanelli, A; Ravetti, JL; Vigo, V | 1 |
Borghesi, S; Hawkins, MA; Tait, D | 1 |
Cheng, AL; Hsu, C; Hu, FC; Huang, TC; Kuo, SH; Lin, CC; Shih, JY; Yang, CH; Yang, PC; Yu, CJ | 1 |
Hansen, HH; Hansen, M; Joss, RA; Renard, J; Rozencweig, M | 1 |
Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Saiki, S; Usami, M | 1 |
Gottschlich, S; Lippert, BM; Schade, W; Werner, JA | 1 |
Lorvidhaya, V | 1 |
Bianco, A; Cavaniglia, G; Frattina, A; Lunghi, F; Migliorini, V; Paccagnella, A; Pappagallo, GL; Segati, R; Sileni, VC; Zorat, P | 1 |
Court, B; Culine, S; Droz, JP; Fadel, E; Haie-Meder, C; Kattan, J; Perrin, JL; Wibault, P | 1 |
Babiĭ, IaS; Bolgova, LS; Galakhin, KA; Iugrinov, OG; Klapchuk, AG; Pozmogov, AI; Rodzaevskiĭ, SA; Tuganova, TN | 1 |
Azhar, T; Cheirsilpa, A; Kang, SB; Lee, HP; Lorvidhaya, V; Manalo, A; Tattersall, MH; Vootiprux, V; Wong, F; Yen, MS | 1 |
Cvitkovic, E; Elias, D; Fizazi, K; Gandia, D; Girinsky, T; Guillot, T; Kac, J; Kayitalire, L; Rougier, P; Spielmann, M | 1 |
Kobayashi, H; Obata, K | 1 |
Görögh, T; Lippert, BM; Rudert, H; Schade, W; Werner, JA | 1 |
Bader, H; Eisenberger, F; Guhl, L; Jipp, P; Nunnensiek, C; Rassweiler, J; Ruether, U; Schmidt, A; Stilz, S | 1 |
Andreyev, HJ; Cunningham, D; Hill, AS; Norman, AR; Padhani, AR; Ross, PJ; Webb, A | 1 |
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
Adamo, V; Altavilla, G; Caristi, N; Chiofalo, G; Maisano, R; Pergolizzi, S; Scimone, A; Settineri, N | 1 |
Tsukuda, M | 1 |
Ishibashi, T; Kaneko, M; Kitada, H; Kobayashi, T; Kohyama, A; Kuwae, C; Minaguchi, R; Ohtsuka, H; Ono, I | 1 |
Dutkowski, P; Fink, U; Gabbert, HE; Heep, H; Sarbia, M; Seeber, S; Stahl, M; Willers, R | 1 |
Hsu, CY; Jan, JS; Lin, JC; Wong, DY | 1 |
Aota, Y; Yoshida, K | 1 |
Hirokawa, K; Miyamoto, T; Saiwai, S; Tashiro, T; Usuki, N | 1 |
Chen, Y; Lin, WC; Perng, RP; Tsai, CM; Whang-Peng, J; Wu, HW; Yang, KY | 1 |
Budach, W | 1 |
Harper, PG; Karapetis, CS; Strickland, AH; Yip, D | 1 |
Burian, M; Czerny, C; Formanek, M; Kletzmayr, J; Kornek, G; Quint, C; Thurnher, D | 1 |
Frieling, T; Hartmann, KA; Heep, H; Heise, JW; Röher, HD; Sarbia, M | 1 |
Bakirtaş, H; Ersoy, H; Imamoğlu, MA; Sertçelik, AN; Yiğitbaşi, O | 1 |
de Oliveira, C; Guastalla, JP; Monfardini, S; Renard, J; van der Burg, ME; Vermorken, JB | 1 |
Baroncelli, G; La Monica, MM | 1 |
Alftan, H; Lehtovirta, P; Leminen, A; Stenman, UH | 1 |
Benjachai, W; Cheirsilpa, A; Kosiyatrakul, T; Puriphat, S; Tangkrutt, S | 1 |
Akiyama, M; Inoue, Y; Sumiyoshi, Y; Yokota, K | 1 |
Azli, N; Bachouchi, M; Boussen, H; Cortes-Funes, H; Cvitkovic, E; Eschwege, F; Gasmi, J; Kalifa, C; Rahal, M; Schwaab, G | 1 |
Haase, S; Hemmer, J; Kreidler, J; Thein, T | 1 |
Armas, A; Asins, J; Calero, F; Iglesias, J; Jimeno, J; Mendaña, J; Murillo, F; Rementeria, A; Rodriguez-Escudero, F; Ugalde, F | 1 |
Ali, NM; Eissa, S; Elattar, I; Elsebai, I; Gad el Mawla, N; Habboubi, N; Hamza, MR; Khaled, H; Magrath, I; Mansour, MA | 1 |
Ban, J; Bistrović, M; Dujmović, I; Kolarić, K; Roth, A | 1 |
Kumanov, Kh; Ormanov, I; Tsvetkov, M | 1 |
Choy, DT; Ma, HK; Ngan, HY; Sham, JS; Wong, LC | 1 |
Arai, R; Fukuoka, M; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, M; Kodama, N; Kubota, K; Tsuruta, M; Yamamoto, M | 1 |
Abad-Esteve, A; Fernandez, C; Monras, P; Moreno, I; Morera, J; Ribas-Mundo, M; Rosell, R; Ruiz, J | 1 |
Bertetto, O; Calciati, A; Clerico, M; Dongiovanni, V | 1 |
Bosl, GJ; Howard, J; Magee, MJ; Wittes, RE | 1 |
2 review(s) available for epirubicin and Carcinoma, Epidermoid
Article | Year |
---|---|
Experimental studies on the phototoxic effect of cytostatic agents. Results and outlook.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Laser Therapy; Maximum Allowable Concentration; Mouth; Mouth Neoplasms; Photochemotherapy | 1995 |
[Treatment for recurrent head and neck carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Combined Modality Therapy; Epirubicin; Fluorouracil; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage | 1998 |
26 trial(s) available for epirubicin and Carcinoma, Epidermoid
Article | Year |
---|---|
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Disease Progression; Disease-Free Survival; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Time Factors; Treatment Failure | 2016 |
A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Platinum Compounds; Survival Analysis | 2008 |
Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Survival Rate; Taxoids; Treatment Failure | 2009 |
A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Epirubicin; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Treatment Outcome; Vitamin B Complex | 2010 |
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Quality of Life; Survival Rate; Treatment Outcome | 2003 |
Symptomatic responses to neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophagogastric junction: are they worth measuring?
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Decision Making; Deglutition; Disease Progression; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Weight Gain | 2006 |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA Topoisomerases, Type II; DNA-Binding Proteins; Endonucleases; Epirubicin; Female; Gemcitabine; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Treatment Outcome | 2008 |
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1994 |
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystectomy; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Japan; Male; Methotrexate; Middle Aged; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Epirubicin and cisplatin in recurrent, metastatic or advanced carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Uterine Cervical Neoplasms | 1995 |
Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis | 1993 |
Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Humans; Middle Aged; Pelvis; Radiotherapy Dosage; Time Factors; Uterine Cervical Neoplasms | 1995 |
Phase II study of 4'epirubicin in advanced squamous cell oesophageal cancer.
Topics: Aged; Carcinoma, Squamous Cell; Epirubicin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged | 1994 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Bleomycin, epirubicin, carboplatin (BECA) in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate | 1997 |
High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Patient Compliance; Prospective Studies; Treatment Outcome | 1999 |
[Intra-arterial chemotherapy for locally advanced bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Male; Radiotherapy Dosage; Survival Rate; Urinary Bladder Neoplasms | 1999 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Salvage Therapy; Survival Analysis; Taiwan; Tamoxifen; Treatment Outcome | 2000 |
[Intra-arterial preoperative chemotherapy versus preoperative radiotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Carotid Artery, External; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Mouth Floor; Mouth Neoplasms; Neoplasm Recurrence, Local; Odds Ratio; Osteoradionecrosis; Preoperative Care; Quality of Life; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Surveys and Questionnaires; Time Factors; Tongue Neoplasms | 2001 |
Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2001 |
Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cost-Benefit Analysis; Drug Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Tomography, X-Ray Computed | 2001 |
Phase II study of weekly 4'-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix: an EORTC Gynaecological Cancer Cooperative Group Study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Epirubicin; Female; Humans; Middle Aged; Palliative Care; Uterine Cervical Neoplasms | 1992 |
Single agent epirubicin in squamous cell cervical cancer. A phase II trial.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Epirubicin; Female; Humans; Middle Aged; Uterine Cervical Neoplasms | 1991 |
A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder.
Topics: Adult; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Postoperative Complications; Schistosomiasis; Survival Rate; Urinary Bladder Neoplasms | 1991 |
A randomized study comparing platinum, doxorubicin, and VP-16 with platinum, 4'-epidoxorubicin, and VP-16 in patients with non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Podophyllotoxin; Random Allocation | 1987 |
56 other study(ies) available for epirubicin and Carcinoma, Epidermoid
Article | Year |
---|---|
Three cases of advanced cutaneous squamous cell carcinoma treated with a combination of carboplatin and epirubicin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Epirubicin; Female; Humans; Male; Middle Aged; Skin Neoplasms | 2020 |
A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Female; Humans; Neoadjuvant Therapy; Paclitaxel; Prognosis | 2019 |
Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Catheterization, Peripheral; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Humans; Length of Stay; Male; Middle Aged; Neoadjuvant Therapy; Perioperative Period; Pulmonary Embolism; Retrospective Studies; Stomach Neoplasms; Survival Rate; Venous Thromboembolism; Venous Thrombosis; Young Adult | 2014 |
Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Humans; Hysterectomy; Ifosfamide; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pelvis; Retrospective Studies; Robotics; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2014 |
Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Composition; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Sarcopenia; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
The Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma Cells.
Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Hepcidins; Humans; Liposomes; Male; Reactive Oxygen Species; Testicular Neoplasms; Tilapia | 2015 |
Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Feasibility Studies; Female; Humans; Hysterectomy; Ifosfamide; Longitudinal Studies; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Retrospective Studies; Robotic Surgical Procedures; Taxoids; Uterine Cervical Neoplasms | 2016 |
Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Conization; Epirubicin; Female; Humans; Hysterectomy; Ifosfamide; Lymph Node Excision; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms; Young Adult | 2008 |
Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms | 2008 |
[A case of aggressive primary squamous cell carcinoma of the breast refractory to preoperative neoadjuvant chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Fatal Outcome; Female; Fluorouracil; Humans; Lung Neoplasms; Neoadjuvant Therapy; Organoplatinum Compounds; Paclitaxel; Vinblastine; Vinorelbine | 2009 |
Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Flow Cytometry; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Taxoids; Vincristine; Xenograft Model Antitumor Assays | 2009 |
Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Outcomes from chemoradiotherapy for patients with esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome | 2011 |
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Palliative Care; Platinum Compounds; Pyrimidines; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2010 |
Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Rate; Survivors; Treatment Outcome | 2011 |
Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prospective Studies; Real-Time Polymerase Chain Reaction; RNA, Messenger; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine | 2011 |
[Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Arteries; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Rate | 2011 |
Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Deglutition Disorders; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Malnutrition; Middle Aged; Neoadjuvant Therapy; Prosthesis Failure; Serum Albumin; Severity of Illness Index; Stents | 2012 |
Nonsurgical management of esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cohort Studies; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Survival Rate; Treatment Outcome | 2011 |
Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Cystectomy; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Japan; Male; Methotrexate; Middle Aged; Paclitaxel; Prognosis; Recurrence; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2011 |
Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Skin Neoplasms | 2013 |
Surgical outcomes of robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer: comparison with early stage disease.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Dose Fractionation, Radiation; Epirubicin; Feasibility Studies; Female; Humans; Hysterectomy; Ifosfamide; Laparoscopy; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Robotics; Safety; Treatment Outcome; Uterine Cervical Neoplasms; Vagina | 2013 |
Epirubicin, Cisplatin, and protracted venous-infusion Fluorouracil in advanced esophagogastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase III as Topic; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Mitomycins; Quality of Life; Stomach Neoplasms | 2002 |
[Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin | 2001 |
An extremely rare case of synchronous occurrence in the larynx of intravascular lymphoma and in situ squamous cell carcinoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphoma; Male; Middle Aged; Prednisone; Time Factors; Treatment Outcome; Vascular Neoplasms; Vincristine | 2003 |
Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Analysis | 2003 |
Photodynamic effects of anthracyclin derivatives on squamous cell carcinoma cell lines of the head and neck.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; Cell Line, Tumor; Dihematoporphyrin Ether; Doxorubicin; Epirubicin; Hematoporphyrins; Humans; Neoplasm Proteins; Otorhinolaryngologic Neoplasms; Photochemotherapy; Photosensitizing Agents | 2004 |
[The value of postoperative arterial infusion chemotherapy in patients with T3 esophageal squamous carcinoma after radical surgery].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Postoperative Period; Prognosis; Proportional Hazards Models | 2005 |
Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Stomach Neoplasms; Survival Rate | 2006 |
[Cytological aspects of therapeutic pathomorphism of lung squamous cell carcinoma during intratumor chemotherapy].
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cytodiagnosis; Doxorubicin; Epirubicin; Humans; Injections, Intralesional; Lung Neoplasms; Middle Aged | 2006 |
Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2007 |
Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epidemiologic Methods; Epirubicin; ErbB Receptors; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Treatment Outcome; Young Adult | 2008 |
Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Outcome | 2008 |
Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Lung Neoplasms; Time Factors | 1984 |
Penile cancer chemotherapy: twelve years' experience at Institut Gustave-Roussy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Epirubicin; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Penile Neoplasms; Survival Rate; Treatment Outcome; Vinblastine | 1993 |
[Effectiveness of transthoracic puncture in the diagnosis and treatment of neoplasms of chest organs].
Topics: Adenocarcinoma; Adolescent; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Doxorubicin; Epirubicin; Evaluation Studies as Topic; Female; Humans; Lung; Lung Neoplasms; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Pneumonectomy; Radiography | 1994 |
[Anthracycline derivatives as photosensitizing agents in photodynamic laser therapy: an in vitro study with squamous epithelial cancer cells of the mouth cavity].
Topics: Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Survival; Doxorubicin; Epirubicin; Humans; Mouth Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1993 |
Intra- and perivesical tumor growth in preoperative staging of bladder cancer: the role of transrectal ultrasonography and high resolution magnetic resonance imaging.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Staging; Preoperative Care; Rectum; Sensitivity and Specificity; Ultrasonography; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Squamous oesophageal cancer can be downstaged using protracted venous infusion of 5-fluorouracil with epirubicin and cisplatin (ECF).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiography; Remission Induction; Survival Analysis | 1995 |
[Intra-arterial infusion chemotherapy for advanced endometrial cancer before surgical treatment].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Endometrial Neoplasms; Epirubicin; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Mitomycin; Preoperative Care | 1998 |
Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclin D1; Epirubicin; Esophageal Neoplasms; Esophagus; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Mucous Membrane; Prognosis; Survival Rate | 1999 |
[Intraarterial chemotherapy for uterine cervical adenocarcinoma: evaluation of its efficacy as neoadjuvant therapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Middle Aged; Mitomycin; Neoadjuvant Therapy; Treatment Outcome; Uterine Cervical Neoplasms | 1999 |
Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cortisone; Epirubicin; Fatal Outcome; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Nasopharyngeal Neoplasms; Plasma; Plasma Exchange; Renal Dialysis | 2001 |
Intravesical epirubicin treatment following TUR in superficial bladder tumours.
Topics: Administration, Intravesical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Urethra; Urinary Bladder Neoplasms; Urologic Surgical Procedures | 2001 |
Epirubicin, methotrexate and bleomycin (EMB) in the treatment of recurrent epidermoid cancer of the head and neck.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged | 1992 |
Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Middle Aged; Serpins; Trypsin Inhibitor, Kazal Pancreatic; Uterine Cervical Neoplasms | 1992 |
Primary chemotherapy for locally advanced uterine cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Middle Aged; Nausea; Survival Rate; Uterine Cervical Neoplasms; Vomiting | 1992 |
[Intra-arterial infusion chemotherapy of advanced bladder cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Male; Prognosis; Urinary Bladder Neoplasms | 1992 |
High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Child; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Pilot Projects; Survival Analysis | 1990 |
Monitoring of intra-arterial treatment with epirubicin and cisplatin in oral carcinoma by DNA flow cytometry.
Topics: Carcinoma, Squamous Cell; Cisplatin; DNA, Neoplasm; Epirubicin; Flow Cytometry; Humans; Infusions, Intra-Arterial; Mouth Neoplasms; Ploidies | 1991 |
Combination of 4-epi-doxorubicin and irradiation--a new approach in the treatment of locoregionally advanced inoperable esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Palliative Care; Pilot Projects | 1986 |
[Adjuvant chemotherapy with biocisplatin, methotrexate and biocarbazine in advanced bladder tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dacarbazine; Drug Evaluation; Epirubicin; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Urinary Bladder Neoplasms; Vinblastine | 1989 |
4-epidoxorubicin in recurrent cervical cancer.
Topics: Adult; Carcinoma, Squamous Cell; Epirubicin; Female; Heart Diseases; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1989 |
[A phase II study of epirubicin in advanced lung cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea | 1986 |
Phase II trial of weekly 4-epi-doxorubicin (epirubicin) in squamous cell carcinoma of the head and neck.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Epirubicin; Head and Neck Neoplasms; Humans | 1987 |
Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Doxorubicin; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Platelet Count | 1985 |